课题基金 / 基金详情

TRANSGENIC MICE CONTAINING HUMAN HEMOGLOBIN S

TRANSGENIC MICE CONTAINING HUMAN HEMOGLOBIN S
含有人血红蛋白 S 的转基因小鼠
批准号:
6241723
负责人:
FRANK F COSTANTINI
金额:
$22.53万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 1998-03-31

项目摘要

项目成果

FRANK F COSTANTINI的其他基金

相关文献

中文摘要
翻译
而血红蛋白S和镰刀的分子和细胞性质 已经对细胞进行了详细的研究,导致血管- 镰刀的闭塞、疼痛危象和其他病理生理方面 细胞疾病仍然知之甚少。这个项目的最终目的是 是制造一种镰状细胞病的小鼠模型,这将是 急慢性血管闭塞的体内研究具有重要价值 过程,以及开发治疗方法。我们研究的转基因模型 到目前为止,其他人培育出的一种基本类似于镰状细胞的特征,但 没有表现出许多纯合子镰状细胞的严重症状 疾病。一个直接的目标是进一步确定转基因生物的特征 我们到目前为止已经生产出了小鼠模型,并一起繁育出不同的 提高Hb S(或Hb变异体)表达的转基因株系 SAD),并有可能增加表型效应。然而, 转基因方法的成功似乎受到内源基因的限制。 老鼠珠蛋白,它与人类珠蛋白链结合,稀释 人类Hbs.这项技术现在存在于生产新的老鼠模型 哪种内源性血红蛋白完全被人的HbS取代? 目的,我们将在小鼠的α和α基因中产生有针对性的突变 胚胎干细胞中同源重组的β-珠蛋白基因座 细胞,删除小鼠成体的α-和β-珠蛋白基因。这些 突变的珠蛋白基因座将被引入小鼠生殖系,其中 它们将(通过繁殖)与人类阿尔法和人类贝塔相结合 珠蛋白转基因。在另一种战略中,我们将直接替换 小鼠成体β-珠蛋白基因和人类β基因,以及 小鼠成体α珠蛋白基因与两个人类成体α珠蛋白 基因,通过在ES细胞中进行基因打靶。由此产生的小鼠将是 其特征是确定小鼠Hb替换的程度 S与人类Hb建立了镰状细胞疾病的模型。
英文摘要
While the molecular and cellular properties of hemoglobin S and sickle cells have been studied in detail, the processes leading to vaso- occlusion, painful crisis and other pathophysiological aspects of sickle cell disease remain poorly understood. The ultimate aim of this project is to produce a mouse model of sickle cell disease, which would be of great value for in vivo studies of acute and chronic vaso-occlusive processes, and for developing therapies. The transgenic models that we an others have produced to date generally resemble sickle cell trait, but do not display many of the severe symptoms of homozygous sickle cell disease. One immediate aim is to further characterize the transgenic mouse models we have produced so far, and to breed together different transgenic lines to increase the expression of Hb S (or the variant Hb SAD) and potentially increase the phenotypic effects. However, the success of transgenic approach appears to be limited by the endogenous mouse globins, which combine with human globin chains and dilute the human Hb S. The technology now exists to produce new mouse models in which endogenous hemoglobin is entirely replaced by human Hb S. For this purpose, we will produce targeted mutations in the murine alpha- and beta-globin loci through homologous recombination in embryonic stem (ES) cells, deleting the mouse adult alpha- and beta-globin genes. these mutant globin loci will be introduced into the mouse germ line, where they will be combined (by breeding) with human alpha and human betaS globin transgenes. In an alternative strategy, we will directly replace the mouse adult beta-globin genes with the human betaS gene, and the mouse adult alpha globin genes with the two human adult alpha globin genes, through gene targeting in ES cells. The resulting mice will be characterized to determine the extent to which replacement of mouse Hb with human Hb S results in a model of sickle cell disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRANSGENIC MODLES AND GENETIC MODIFIERS OF SICKLE CELL DISEASE
TRANSGENIC MODLES AND GENETIC MODIFIERS OF SICKLE CELL DISEASE
TRANSGENIC MODLES AND GENETIC MODIFIERS OF SICKLE CELL DISEASE
TRANSGENIC MODLES AND GENETIC MODIFIERS OF SICKLE CELL DISEASE